A Single Session of Virtual Reality Improved Tiredness, Shortness of Breath, Anxiety, Depression and Well-Being in Hospitalized Individuals with COVID-19: A Randomized Clinical Trial.
COVID-19
occupational therapy
symptom assessment
virtual reality
well-being
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
19 May 2022
19 May 2022
Historique:
received:
12
04
2022
revised:
09
05
2022
accepted:
16
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
In 2020, the world was surprised by the spread and mass contamination of the new Coronavirus (COVID-19). COVID-19 produces symptoms ranging from a common cold to severe symptoms that can lead to death. Several strategies have been implemented to improve the well-being of patients during their hospitalization, and virtual reality (VR) has been used. However, whether patients hospitalized for COVID-19 can benefit from this intervention remains unclear. Therefore, this study aimed to investigate whether VR contributes to the control of pain symptoms, the sensation of dyspnea, perception of well-being, anxiety, and depression in patients hospitalized with COVID-19. A randomized, double-blind clinical trial was designed. Patients underwent a single session of VR and usual care. The experimental group ( The experimental group reported a significant decrease in tiredness, shortness of breath, anxiety, and an increase in the feeling of well-being, whereas the control group showed improvement only in the tiredness and anxiety. VR is a resource that may improve the symptoms of tiredness, shortness of breath, anxiety, and depression in patients hospitalized with COVID-19. Future studies should investigate the effect of multiple VR sessions on individuals with COVID-19.
Sections du résumé
BACKGROUND
BACKGROUND
In 2020, the world was surprised by the spread and mass contamination of the new Coronavirus (COVID-19). COVID-19 produces symptoms ranging from a common cold to severe symptoms that can lead to death. Several strategies have been implemented to improve the well-being of patients during their hospitalization, and virtual reality (VR) has been used. However, whether patients hospitalized for COVID-19 can benefit from this intervention remains unclear. Therefore, this study aimed to investigate whether VR contributes to the control of pain symptoms, the sensation of dyspnea, perception of well-being, anxiety, and depression in patients hospitalized with COVID-19.
METHODS
METHODS
A randomized, double-blind clinical trial was designed. Patients underwent a single session of VR and usual care. The experimental group (
RESULTS
RESULTS
The experimental group reported a significant decrease in tiredness, shortness of breath, anxiety, and an increase in the feeling of well-being, whereas the control group showed improvement only in the tiredness and anxiety.
CONCLUSIONS
CONCLUSIONS
VR is a resource that may improve the symptoms of tiredness, shortness of breath, anxiety, and depression in patients hospitalized with COVID-19. Future studies should investigate the effect of multiple VR sessions on individuals with COVID-19.
Identifiants
pubmed: 35629250
pii: jpm12050829
doi: 10.3390/jpm12050829
pmc: PMC9143462
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministero della Salute
ID : Ricerca Corrente
Références
Arq Neuropsiquiatr. 1998 Sep;56(3B):605-12
pubmed: 9850757
Handb Clin Neurol. 2019;160:407-418
pubmed: 31277865
J Cell Physiol. 2016 Feb;231(2):275-87
pubmed: 26238976
Eur Psychiatry. 2020 May 29;63(1):e58
pubmed: 32466820
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Rev Assoc Med Bras (1992). 2020 Apr;66(4):547-557
pubmed: 32578794
Scand J Rehabil Med. 1984;16(3):125-32
pubmed: 6494836
PLoS One. 2016 Dec 20;11(12):e0167523
pubmed: 27997539
Curr Opin Support Palliat Care. 2019 Sep;13(3):200-210
pubmed: 31306187
Neurol Sci. 2020 Sep;41(9):2343-2344
pubmed: 32661885
Clin J Pain. 2008 May;24(4):299-304
pubmed: 18427228
Euro Surveill. 2020 Feb;25(5):
pubmed: 32019636
Ann Phys Rehabil Med. 2022 Nov;65(6):101609
pubmed: 34839056
Front Neurol. 2020 Sep 15;11:926
pubmed: 33041963
Rev Saude Publica. 1995 Oct;29(5):355-63
pubmed: 8731275
J Telemed Telecare. 2021 Dec 1;:1357633X211054839
pubmed: 34851211
Rev Saude Publica. 2006 Aug;40(4):712-9
pubmed: 16906312
JMIR Ment Health. 2016 Jun 27;3(2):e28
pubmed: 27349654
Nurs Clin North Am. 1993 Jun;28(2):373-84
pubmed: 8516180
Clin Microbiol Rev. 2020 Jun 24;33(4):
pubmed: 32580969
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
Rev Bras Epidemiol. 2013 Sep;16(3):644-57
pubmed: 24896278
Nature. 1998 May 21;393(6682):266-8
pubmed: 9607763
Cancer. 2000 May 1;88(9):2164-71
pubmed: 10813730
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Eur J Phys Rehabil Med. 2021 Jun;57(3):319-320
pubmed: 34281335
J Med Internet Res. 2020 Jul 7;22(7):e14178
pubmed: 32673224
Lancet Public Health. 2020 May;5(5):e256
pubmed: 32199471
Clin Psychol Rev. 2010 Dec;30(8):1011-8
pubmed: 20691523
J Pharmacol Pharmacother. 2010 Jul;1(2):100-7
pubmed: 21350618
J Clin Med. 2021 Jan 18;10(2):
pubmed: 33477733